DexCom
DXCM
#1002
Rank
โ‚น2.238 T
Marketcap
โ‚น5,801
Share price
-1.80%
Change (1 day)
-5.19%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2025 (TTM): โ‚น408.23 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is โ‚น439.25 Billion. an increase over the revenue in the year 2024 that were of โ‚น345.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น418.50 B20.96%
2024 โ‚น345.97 B14.73%
2023 โ‚น301.55 B25.24%
2022 โ‚น240.78 B32.12%
2021 โ‚น182.24 B29.34%
2020 โ‚น140.90 B33.87%
2019 โ‚น105.25 B45.92%
2018 โ‚น72.13 B57.23%
2017 โ‚น45.87 B17.76%
2016 โ‚น38.95 B45.83%
2015 โ‚น26.71 B62.62%
2014 โ‚น16.42 B66.19%
2013 โ‚น9.88 B80.78%
2012 โ‚น5.46 B35.53%
2011 โ‚น4.03 B85.14%
2010 โ‚น2.17 B58.17%
2009 โ‚น1.37 B191.39%
2008 โ‚น0.47 B160.38%
2007 โ‚น0.18 B88.96%
2006 โ‚น96.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.874 T 1,920.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น4.176 T 850.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น3.343 T 661.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
โ‚น2.065 T 370.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
โ‚น571.68 B 30.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
โ‚น94.87 B-78.40%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
โ‚น255.75 B-41.78%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
โ‚น289.64 B-34.06%๐Ÿ‡บ๐Ÿ‡ธ USA